Flu Vaccine Leader Seqirus Invests In Self-Amplifying mRNA

Roberta Duncan To Head Up Progam

 
• By Andrew McConaghie
  
Flu Vaccine NHS
Seqirus has been boosted by better-than-expected flu vaccine sales, but must invest to keep ahead of new competitors
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip